Annual Net Income
-$4.71 B
-$13.08 B-156.37%
31 December 2023
Summary:
Moderna annual net profit is currently -$4.71 billion, with the most recent change of -$13.08 billion (-156.37%) on 31 December 2023. During the last 3 years, it has fallen by -$16.92 billion (-138.63%). MRNA annual net income is now -138.63% below its all-time high of $12.20 billion, reached on 31 December 2021.MRNA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$13.00 M
+$1.29 B+101.02%
30 September 2024
Summary:
Moderna quarterly net profit is currently $13.00 million, with the most recent change of +$1.29 billion (+101.02%) on 30 September 2024. Over the past year, it has dropped by -$204.00 million (-94.01%). MRNA quarterly net income is now -99.73% below its all-time high of $4.87 billion, reached on 31 December 2021.MRNA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$2.22 B
+$3.64 B+62.09%
30 September 2024
Summary:
Moderna TTM net profit is currently -$2.22 billion, with the most recent change of +$3.64 billion (+62.09%) on 30 September 2024. Over the past year, it has increased by +$2.49 billion (+52.82%). MRNA TTM net income is now -115.19% below its all-time high of $14.64 billion, reached on 31 March 2022.MRNA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -94.0% | +52.8% |
| 3 y3 years | -138.6% | -99.7% | -118.2% |
| 5 y5 years | -817.1% | +110.5% | -332.7% |
MRNA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -138.6% | at low | -99.7% | +100.4% | -115.2% | +62.7% |
| 5 y | 5 years | -138.6% | at low | -99.7% | +100.4% | -115.2% | +62.7% |
| alltime | all time | -138.6% | at low | -99.7% | +100.4% | -115.2% | +62.7% |
Moderna Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.00 M(-101.0%) | -$2.22 B(-62.1%) |
| June 2024 | - | -$1.28 B(+8.9%) | -$5.87 B(-1.7%) |
| Mar 2024 | - | -$1.18 B(-641.5%) | -$5.97 B(+26.6%) |
| Dec 2023 | -$4.71 B(-156.4%) | $217.00 M(-106.0%) | -$4.71 B(+36.0%) |
| Sept 2023 | - | -$3.63 B(+163.0%) | -$3.47 B(-387.2%) |
| June 2023 | - | -$1.38 B(-1846.8%) | $1.21 B(-74.8%) |
| Mar 2023 | - | $79.00 M(-94.6%) | $4.78 B(-42.8%) |
| Dec 2022 | $8.36 B(-31.5%) | $1.47 B(+40.5%) | $8.36 B(-28.9%) |
| Sept 2022 | - | $1.04 B(-52.5%) | $11.77 B(-16.3%) |
| June 2022 | - | $2.20 B(-39.9%) | $14.05 B(-4.0%) |
| Mar 2022 | - | $3.66 B(-24.9%) | $14.64 B(+20.0%) |
| Dec 2021 | $12.20 B(-1733.5%) | $4.87 B(+46.1%) | $12.20 B(+72.8%) |
| Sept 2021 | - | $3.33 B(+19.9%) | $7.06 B(+102.0%) |
| June 2021 | - | $2.78 B(+127.7%) | $3.50 B(+484.4%) |
| Mar 2021 | - | $1.22 B(-547.3%) | $598.00 M(-180.1%) |
| Dec 2020 | -$747.00 M(+45.3%) | -$273.00 M(+17.2%) | -$747.00 M(+25.1%) |
| Sept 2020 | - | -$233.00 M(+99.1%) | -$597.27 M(+22.5%) |
| June 2020 | - | -$117.00 M(-5.6%) | -$487.48 M(-3.5%) |
| Mar 2020 | - | -$124.00 M(+0.6%) | -$505.42 M(-1.7%) |
| Dec 2019 | -$514.00 M(+33.6%) | -$123.27 M(+0.0%) | -$514.00 M(-3.4%) |
| Sept 2019 | - | -$123.22 M(-8.7%) | -$532.16 M(+8.8%) |
| June 2019 | - | -$134.94 M(+1.8%) | -$489.27 M(+10.0%) |
| Mar 2019 | - | -$132.58 M(-6.3%) | -$444.93 M(+15.6%) |
| Dec 2018 | -$384.73 M(+50.3%) | -$141.43 M(+76.1%) | -$384.73 M(+36.8%) |
| Sept 2018 | - | -$80.33 M(-11.3%) | -$281.25 M(+39.3%) |
| June 2018 | - | -$90.60 M(+25.2%) | -$201.89 M(+79.5%) |
| Mar 2018 | - | -$72.38 M(+90.7%) | -$112.46 M(+173.2%) |
| Dec 2017 | -$255.92 M(+18.4%) | -$37.94 M(+3802.9%) | -$41.17 M(+1006.2%) |
| Sept 2017 | - | -$972.20 K(-17.0%) | -$3.72 M(+30.7%) |
| June 2017 | - | -$1.17 M(+8.2%) | -$2.85 M(+57.7%) |
| Mar 2017 | - | -$1.08 M(+118.5%) | -$1.81 M(+115.6%) |
| Dec 2016 | -$216.21 M(-6579.2%) | - | - |
| Dec 2016 | - | -$495.60 K(+401.1%) | -$837.90 K(-484.9%) |
| Sept 2016 | - | -$98.90 K(-23.5%) | $217.70 K(-87.7%) |
| June 2016 | - | -$129.20 K(+13.1%) | $1.78 M(-36.8%) |
| Mar 2016 | - | -$114.20 K(-120.4%) | $2.81 M(-15.8%) |
| Dec 2015 | $3.34 M(-151.5%) | $560.00 K(-61.6%) | $3.34 M(-61.1%) |
| Sept 2015 | - | $1.46 M(+61.4%) | $8.58 M(<-9900.0%) |
| June 2015 | - | $904.00 K(+118.4%) | -$2000.00(-100.1%) |
| Mar 2015 | - | $414.00 K(-92.9%) | $3.02 M(-146.5%) |
| Dec 2014 | -$6.48 M(+312.3%) | $5.80 M(-181.5%) | -$6.48 M(-54.5%) |
| Sept 2014 | - | -$7.12 M(-281.7%) | -$14.24 M(+75.9%) |
| June 2014 | - | $3.92 M(-143.2%) | -$8.10 M(-32.7%) |
| Mar 2014 | - | -$9.08 M(+362.2%) | -$12.03 M(+665.4%) |
| Dec 2013 | -$1.57 M(-83.5%) | -$1.96 M(+101.2%) | -$1.57 M(-57.1%) |
| Sept 2013 | - | -$976.00 K(>+9900.0%) | -$3.66 M(-17.5%) |
| June 2013 | - | -$7000.00(-100.5%) | -$4.43 M(+32.5%) |
| Mar 2013 | - | $1.38 M(-134.0%) | -$3.35 M(-64.9%) |
| Dec 2012 | -$9.55 M(-67.6%) | -$4.05 M(+131.5%) | -$9.55 M(-59.0%) |
| Sept 2012 | - | -$1.75 M(-262.0%) | -$23.28 M(-10.2%) |
| June 2012 | - | $1.08 M(-122.4%) | -$25.92 M(-15.3%) |
| Mar 2012 | - | -$4.82 M(-72.9%) | -$30.58 M(+3.9%) |
| Dec 2011 | -$29.42 M(+6.0%) | -$17.79 M(+305.4%) | -$29.42 M(+67.9%) |
| Sept 2011 | - | -$4.39 M(+22.4%) | -$17.53 M(-18.1%) |
| June 2011 | - | -$3.58 M(-2.2%) | -$21.41 M(-2.4%) |
| Mar 2011 | - | -$3.67 M(-37.8%) | -$21.93 M(-21.0%) |
| Dec 2010 | -$27.75 M(+244.9%) | -$5.89 M(-28.8%) | -$27.75 M(+22.5%) |
| Sept 2010 | - | -$8.27 M(+101.7%) | -$22.65 M(+5.9%) |
| June 2010 | - | -$4.10 M(-56.8%) | -$21.39 M(-13.8%) |
| Mar 2010 | - | -$9.49 M(+1108.9%) | -$24.82 M(+208.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$8.05 M(-86.4%) | -$785.00 K(-88.8%) | -$8.05 M(-58.9%) |
| Sept 2009 | - | -$7.01 M(-6.9%) | -$19.56 M(-31.7%) |
| June 2009 | - | -$7.53 M(-203.4%) | -$28.62 M(-19.2%) |
| Mar 2009 | - | $7.28 M(-159.2%) | -$35.42 M(-40.2%) |
| Dec 2008 | -$59.22 M(+13.1%) | -$12.30 M(-23.5%) | -$59.22 M(+0.5%) |
| Sept 2008 | - | -$16.07 M(+12.1%) | -$58.93 M(-0.6%) |
| June 2008 | - | -$14.33 M(-13.2%) | -$59.31 M(+3.4%) |
| Mar 2008 | - | -$16.52 M(+37.5%) | -$57.35 M(+9.5%) |
| Dec 2007 | -$52.37 M(+94.9%) | -$12.02 M(-27.0%) | -$52.37 M(+2.7%) |
| Sept 2007 | - | -$16.45 M(+33.0%) | -$51.02 M(+20.4%) |
| June 2007 | - | -$12.37 M(+7.2%) | -$42.38 M(+38.6%) |
| Mar 2007 | - | -$11.54 M(+8.2%) | -$30.57 M(+13.7%) |
| Dec 2006 | -$26.88 M(-16.4%) | -$10.66 M(+36.6%) | -$26.88 M(+6.9%) |
| Sept 2006 | - | -$7.81 M(+1294.3%) | -$25.13 M(-3.8%) |
| June 2006 | - | -$560.00 K(-92.9%) | -$26.14 M(-22.9%) |
| Mar 2006 | - | -$7.85 M(-12.0%) | -$33.92 M(+5.5%) |
| Dec 2005 | -$32.16 M(+12.4%) | -$8.92 M(+1.2%) | -$32.16 M(+10.3%) |
| Sept 2005 | - | -$8.81 M(+5.6%) | -$29.16 M(+4.5%) |
| June 2005 | - | -$8.34 M(+37.1%) | -$27.91 M(+3.2%) |
| Mar 2005 | - | -$6.09 M(+2.8%) | -$27.05 M(-5.4%) |
| Dec 2004 | -$28.61 M(+1236.2%) | -$5.92 M(-21.7%) | -$28.61 M(+0.0%) |
| Sept 2004 | - | -$7.55 M(+0.9%) | -$28.61 M(+4.8%) |
| June 2004 | - | -$7.49 M(-2.0%) | -$27.30 M(+298.0%) |
| Mar 2004 | - | -$7.64 M(+29.2%) | -$6.86 M(+220.4%) |
| Dec 2003 | -$2.14 M(-84.1%) | -$5.92 M(-5.3%) | -$2.14 M(+6.0%) |
| Sept 2003 | - | -$6.25 M(-148.3%) | -$2.02 M(-344.7%) |
| June 2003 | - | $12.95 M(-542.8%) | $825.00 K(-106.1%) |
| Mar 2003 | - | -$2.92 M(-49.5%) | -$13.59 M(+0.9%) |
| Dec 2002 | -$13.47 M(+45.9%) | -$5.79 M(+70.1%) | -$13.47 M(+25.9%) |
| Sept 2002 | - | -$3.41 M(+132.4%) | -$10.70 M(+17.4%) |
| June 2002 | - | -$1.47 M(-47.7%) | -$9.12 M(-6.1%) |
| Mar 2002 | - | -$2.80 M(-7.4%) | -$9.71 M(+5.3%) |
| Dec 2001 | -$9.23 M(-4.7%) | -$3.03 M(+65.8%) | -$9.23 M(+23.5%) |
| Sept 2001 | - | -$1.82 M(-11.5%) | -$7.47 M(-22.5%) |
| June 2001 | - | -$2.06 M(-10.9%) | -$9.64 M(-1.9%) |
| Mar 2001 | - | -$2.31 M(+82.4%) | -$9.83 M(+1.5%) |
| Dec 2000 | -$9.69 M(+15.4%) | -$1.27 M(-68.2%) | -$9.69 M(-13.6%) |
| Sept 2000 | - | -$4.00 M(+77.4%) | -$11.22 M(+23.0%) |
| June 2000 | - | -$2.25 M(+3.6%) | -$9.13 M(+10.3%) |
| Mar 2000 | - | -$2.17 M(-22.4%) | -$8.27 M(-0.3%) |
| Dec 1999 | -$8.40 M(+833.3%) | -$2.80 M(+47.4%) | -$8.30 M(+23.9%) |
| Sept 1999 | - | -$1.90 M(+35.7%) | -$6.70 M(+34.0%) |
| June 1999 | - | -$1.40 M(-36.4%) | -$5.00 M(+47.1%) |
| Mar 1999 | - | -$2.20 M(+83.3%) | -$3.40 M(+240.0%) |
| Dec 1998 | -$900.00 K(-80.0%) | -$1.20 M(+500.0%) | -$1.00 M(-41.2%) |
| Sept 1998 | - | -$200.00 K(-200.0%) | -$1.70 M(-39.3%) |
| June 1998 | - | $200.00 K(0.0%) | -$2.80 M(-28.2%) |
| Mar 1998 | - | $200.00 K(-110.5%) | -$3.90 M(-13.3%) |
| Dec 1997 | -$4.50 M(+1025.0%) | -$1.90 M(+46.2%) | -$4.50 M(+73.1%) |
| Sept 1997 | - | -$1.30 M(+44.4%) | -$2.60 M(+116.7%) |
| June 1997 | - | -$900.00 K(+125.0%) | -$1.20 M(+300.0%) |
| Mar 1997 | - | -$400.00 K(-500.0%) | -$300.00 K(-400.0%) |
| Dec 1996 | -$400.00 K(-500.0%) | - | - |
| Sept 1996 | - | $100.00 K(-50.0%) | $100.00 K(-150.0%) |
| June 1996 | $100.00 K(-200.0%) | - | - |
| Mar 1996 | - | $200.00 K(-200.0%) | -$200.00 K(-50.0%) |
| Dec 1995 | - | -$200.00 K(0.0%) | -$400.00 K(+300.0%) |
| June 1995 | -$100.00 K(-150.0%) | -$200.00 K(-300.0%) | -$100.00 K(-150.0%) |
| Sept 1994 | - | $100.00 K(0.0%) | $200.00 K(-33.3%) |
| June 1994 | $200.00 K | $100.00 K(-50.0%) | $300.00 K(+50.0%) |
| Sept 1993 | - | $200.00 K | $200.00 K |
FAQ
- What is Moderna annual net profit?
- What is the all time high annual net income for Moderna?
- What is Moderna quarterly net profit?
- What is the all time high quarterly net income for Moderna?
- What is Moderna quarterly net income year-on-year change?
- What is Moderna TTM net profit?
- What is the all time high TTM net income for Moderna?
- What is Moderna TTM net income year-on-year change?
What is Moderna annual net profit?
The current annual net income of MRNA is -$4.71 B
What is the all time high annual net income for Moderna?
Moderna all-time high annual net profit is $12.20 B
What is Moderna quarterly net profit?
The current quarterly net income of MRNA is $13.00 M
What is the all time high quarterly net income for Moderna?
Moderna all-time high quarterly net profit is $4.87 B
What is Moderna quarterly net income year-on-year change?
Over the past year, MRNA quarterly net profit has changed by -$204.00 M (-94.01%)
What is Moderna TTM net profit?
The current TTM net income of MRNA is -$2.22 B
What is the all time high TTM net income for Moderna?
Moderna all-time high TTM net profit is $14.64 B
What is Moderna TTM net income year-on-year change?
Over the past year, MRNA TTM net profit has changed by +$2.49 B (+52.82%)